Remove Containment Remove Contamination Remove Genetics
article thumbnail

Risk Assessment for use of Engineered Genetic Materials in Clinical Research

Advarra

The use of engineered genetic materials in clinical trials is rapidly expanding, with potential applications for genetic vaccines, gene-modified cellular therapies, and gene therapies. A key part of the IBC’s evaluation is assessing the risks posed by the engineered genetic materials.

article thumbnail

Top 12 Foods with the Most Pesticides

XTalks

According to the EWG, about 95 percent of nonorganic strawberries, certain leafy greens (including spinach, kale, collard and mustard greens), grapes, peaches and pears contain detectable levels of pesticides. Children and farmworkers are among the most vulnerable, and exposure can lead to genetic damage and impaired neurodevelopment.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Why Plant-Based Meat Safety Differs From That of Animal Protein

XTalks

Those who seek shorter ingredient lists and cleaner labels may object to plant-based meat due to the many additives and genetically modified proteins that tend to be crucial components of its formulation. Since most plant-based meats contain concentrated protein isolates, consumers may receive much higher doses of potential allergens.

Protein 98
article thumbnail

Building Tomorrow’s Therapies Today: The Evolution of Cell Therapy Manufacturing Process

Roots Analysis

Cell therapies are based on the premise that the patients own cells (autologous), or those from a healthy donor (allogeneic), can be genetically re-programmed to combat various diseases. Such procedures require sterile and higher-grade clean rooms, along with regular checks on containment levels.

article thumbnail

HPAPIs – Current Interest of the Pharmaceutical Industry

Roots Analysis

They consist of two or more amino acids and are synthesized naturally from transcription of a sequence of genetic code. This precaution is taken to prevent any potentially harmful contaminant from escaping the production area. This is in contrast to the containment requirements at manufacturing facilities of traditional APIs.

article thumbnail

Cryomacs Freezing Bags – A Critical Component in the Successful Delivery of Biological Samples and Therapies

Roots Analysis

Due to the infrastructure available for processing, freezing and storing of these container systems, blood bags are the preferred container for cell therapy biopreservation. The above figure presents a general overview of the cryopreservation process.

article thumbnail

Outsourcing Biologics Fill Finish Manufacturing : Streamlining the Production Process for Biopharmaceutical Companies

Roots Analysis

Over the years, these large molecules have demonstrated promising therapeutic outcomes in the treatment of myriad of chronic and challenging disorders, including autoimmune disorders, infectious diseases, genetic disorders, and oncological disorders.